— Know what they know.
Not Investment Advice

128940.KS

Hanmi Pharm. Co., Ltd.
1W: +1.9% 1M: -12.2% 3M: +22.0% YTD: -8.5% 1Y: +121.9% 3Y: +105.4% 5Y: +67.6%
₩551,000.00 ($366.24)
+10000.00 (+1.85%)
 
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · ₩6.86T
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₩6.86T ($4.6B)
52W Range214500-647000
Volume75,947
Avg Volume143,398
Beta0.56
Dividend₩250.00
Analyst Ratings
No analyst coverage
Company Info
CEOJae-Hyun Park
Employees2,270
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2010-07-30
14, Wiryeseong-daero
Seoul 05545
KR
82 2 410 9114
About Hanmi Pharm. Co., Ltd.

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms